Ticker Scorecard - PLX Basics Company: Protalix BioTherapeutics, Inc. IPO Date: June 1, 1998 Sector: Healthcare Industry: Biotech Market Cap: $175.98M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 2.82% Avg Daily Range (30 D): $0.06 | 2.43% Avg Daily Range (90 D): $0.04 | 2.34% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .6M Avg Daily Volume (90 D): .46M Trade Size Avg Trade Size (Sh.): 166 Avg Trade Size (Sh.) (30 D): 185 Avg Trade Size (Sh.) (90 D): 231 Institutional Trades Total Inst.Trades: 280 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $7.01M Avg Inst. Trade (90 D): $7.01M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.88M Avg Closing Trade (30 D): $7.01M Avg Closing Trade (90 D): $7.01M Avg Closing Volume: 544.49K     News Jun 12, 2024 @ 3:45 PM Pluxee to acquire Cobee, an innovative Spanish dig... Source: Pluxee N.V Jun 12, 2024 @ 3:45 PM Pluxee signe un accord pour l’acquisition d... Source: Pluxee N.V Jun 12, 2024 @ 3:45 PM Pluxee firma un acuerdo para adquirir Cobee, empre... Source: Pluxee N.V Apr 22, 2024 @ 4:00 PM Declaration of transactions in own shares n 2024/0... Source: Pluxee International Apr 22, 2024 @ 4:00 PM Déclaration des transactions sur actions propre... Source: Pluxee International Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.15 $.04 $-.03 Diluted EPS $-.13 $.03 $-.03 Revenue $ 45.67M $ 17.96M $ 13.47M Gross Profit $ 16.38M $ 9.58M $ 4.02M Net Income / Loss $ -9.61M $ 3.24M $ -2.2M Operating Income / Loss $ -8.91M $ 3.99M $ -2.43M Cost of Revenue $ 29.29M $ 8.38M $ 9.46M Net Cash Flow $ 7.06M $ 3.8M $ M PE Ratio     Splits Dec 20, 2019:   10:1 Jan 03, 2007:   10:1